Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 665
of 34Next
1:

Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.

Miller LD, Liu ET.

Breast Cancer Res. 2007;9(2):206. Review.

PMID: 17397520 [PubMed - indexed for MEDLINE]

2:

[DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications]

Bertucci F, Viens P, Birnbaum D.

Pathol Biol (Paris). 2006 Feb;54(1):49-54. French.

PMID: 16376179 [PubMed - indexed for MEDLINE]

3:

Characterizing disease states from topological properties of transcriptional regulatory networks.

Tuck DP, Kluger HM, Kluger Y.

BMC Bioinformatics. 2006 May 2;7:236.

PMID: 16670008 [PubMed - indexed for MEDLINE]

4:

Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.

Shen R, Ghosh D, Chinnaiyan AM.

BMC Genomics. 2004 Dec 14;5(1):94.

PMID: 15598354 [PubMed - indexed for MEDLINE]

5:

Elucidating the altered transcriptional programs in breast cancer using independent component analysis.

Teschendorff AE, Journée M, Absil PA, Sepulchre R, Caldas C.

PLoS Comput Biol. 2007 Aug;3(8):e161. Epub 2007 Jun 29.

PMID: 17708679 [PubMed - indexed for MEDLINE]

6:

Microarrays in breast cancer research and clinical practice--the future lies ahead.

Gruvberger-Saal SK, Cunliffe HE, Carr KM, Hedenfalk IA.

Endocr Relat Cancer. 2006 Dec;13(4):1017-31. Review.

PMID: 17158752 [PubMed - indexed for MEDLINE]

7:

Improved breast cancer prognosis through the combination of clinical and genetic markers.

Sun Y, Goodison S, Li J, Liu L, Farmerie W.

Bioinformatics. 2007 Jan 1;23(1):30-7. Epub 2006 Nov 26.

PMID: 17130137 [PubMed - indexed for MEDLINE]

8:

Genomics-based prognosis and therapeutic prediction in breast cancer.

Jeffrey SS, Lønning PE, Hillner BE.

J Natl Compr Canc Netw. 2005 May;3(3):291-300. Review.

PMID: 16002001 [PubMed - indexed for MEDLINE]

9:

Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.

Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.

Breast Cancer Res. 2006;8(5):R56.

PMID: 17014703 [PubMed - indexed for MEDLINE]

10:

From description to causality: mechanisms of gene expression signatures in cancer.

Adler AS, Chang HY.

Cell Cycle. 2006 Jun;5(11):1148-51. Epub 2006 Jun 1. Review.

PMID: 16721055 [PubMed - indexed for MEDLINE]

11:

Revealing targeted therapy for human cancer by gene module maps.

Wong DJ, Nuyten DS, Regev A, Lin M, Adler AS, Segal E, van de Vijver MJ, Chang HY.

Cancer Res. 2008 Jan 15;68(2):369-78.

PMID: 18199530 [PubMed - indexed for MEDLINE]

12:

Where are we in genomics?

Hocquette JF.

J Physiol Pharmacol. 2005 Jun;56 Suppl 3:37-70. Review.

PMID: 16077195 [PubMed - indexed for MEDLINE]

13:

Molecular profiling of breast cancer: transcriptomic studies and beyond.

Culhane AC, Howlin J.

Cell Mol Life Sci. 2007 Dec;64(24):3185-200. Review.

PMID: 17957338 [PubMed - indexed for MEDLINE]

14:

Genomics and circulating tumor cells: promising tools for choosing and monitoring adjuvant therapy in patients with early breast cancer?

Dirix L, Van Dam P, Vermeulen P.

Curr Opin Oncol. 2005 Nov;17(6):551-8. Review.

PMID: 16224232 [PubMed - indexed for MEDLINE]

15:

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N, Lahti-Domenici JS, Bruinsma TJ, Warmoes MO, Bernards R, Wessels LF, Van't Veer LJ.

BMC Genomics. 2006 Oct 30;7:278.

PMID: 17074082 [PubMed - indexed for MEDLINE]

16:

From signatures to models: understanding cancer using microarrays.

Segal E, Friedman N, Kaminski N, Regev A, Koller D.

Nat Genet. 2005 Jun;37 Suppl:S38-45. Review.

PMID: 15920529 [PubMed - indexed for MEDLINE]

17:

Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.

Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE.

Cancer Res. 2007 Sep 1;67(17):8065-80. Erratum in: Cancer Res. 2007 Oct 15;67(20):10097.

PMID: 17804718 [PubMed - indexed for MEDLINE]

18:

Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.

Nuyten DS, van de Vijver MJ.

Semin Radiat Oncol. 2008 Apr;18(2):105-14. Review.

PMID: 18314065 [PubMed - indexed for MEDLINE]

19:

Gene expression profiling in malignant lymphomas.

Henrickson SE, Hartmann EM, Ott G, Rosenwald A.

Adv Exp Med Biol. 2007;593:134-46. Review.

PMID: 17265723 [PubMed - indexed for MEDLINE]

20:

Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks.

Gevaert O, De Smet F, Timmerman D, Moreau Y, De Moor B.

Bioinformatics. 2006 Jul 15;22(14):e184-90.

PMID: 16873470 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 665
of 34Next